Amerise Biosciences Stock Price Analysis and Quick Research Report. Is Amerise Biosciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Amerise Biosciences. 

Key Financials -

• Profitability: Profit margin (PAT margin) of the company shows how well a company controls its cost. It is one of the important indicators to show the financial health of the company. Net profit of Amerise Biosciences is Rs 0.0057 Cr. and the compounded growth of profit in the past 3 years is -78.1866991830745%. The PAT margin of Amerise Biosciences is 0%.
• EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Amerise Biosciences , the EPS grew by 104.0724% YOY. 

 Financial Ratios -

• Return on Equity (ROE): Amerise Biosciences has a poor ROE track record. The ROE of Amerise Biosciences is at 0.106% for the latest year.
• P/E Ratio: Relative valuation metrics like the P/E ratio can be used to see if the stock of Amerise Biosciences is worth at the current levels at Rs 0.64. Amerise Biosciences is trading at a current P/E ratio of 1011.1111 and the average historical P/E for the last 5 years was 205.495384861612.
• P/B ratio can be one of the best metrics to value such companies. Currently, Amerise Biosciences is trading at a P/B of 0.787111056450621. The average historical P/B for the last 5 years was 1.30037904115389. This can be compared with the Market price per share in order to know if the stock is undervalued or overvalued.

One can find all the Financial Ratios of Amerise Biosciences in Ticker for free. Also, one can get the intrinsic value of Amerise Biosciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Amerise Biosciences FAQs

Q1. What is Amerise Biosciences share price today?
Ans: The current share price of Amerise Biosciences is Rs 0.64.

Q2. What is the market capitalisation of Amerise Biosciences?
Ans: Amerise Biosciences has a market capitalisation of Rs 4.228416 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Amerise Biosciences?
Ans: The PE ratio of Amerise Biosciences is 86.4864864864865 and the P/B ratio of Amerise Biosciences is 0.787111056450621, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Amerise Biosciences share?
Ans: The 52-week high share price of Amerise Biosciences is Rs 1.45, and the 52-week low share price of Amerise Biosciences is Rs 0.55.

Q5. Does Amerise Biosciences pay dividends?
Ans: Currently, Amerise Biosciences does not pay dividends. Dividend yield of Amerise Biosciences is around 0%.

Q6. What are the face value and book value of Amerise Biosciences shares?
Ans: The face value of Amerise Biosciences shares is Rs 1, while the book value per share of Amerise Biosciences is around Rs 0.8131. Face value is the nominal value set by the company, whereas book value reflects its accounting worth. 

Q7. What are the ROE and ROCE of Amerise Biosciences?
Ans: The ROE of Amerise Biosciences is 0.106% and ROCE of Amerise Biosciences is 0.1451%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q8. Is Amerise Biosciences a good buy for the long term?
Ans: The Amerise Biosciences long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q9. Is Amerise Biosciences undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Amerise Biosciences appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q10. How to check Amerise Biosciences’s financials?
Ans: You can review Amerise Biosciences’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.